Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study

Objective. Several molecules are involved in the pathogenesis of a new bone formation in ankylosing spondylitis (AS). The aim of this study was to evaluate the serum levels of sclerostin in patients with AS as a possible biomarker and to investigate any correlations with radiographic damage, disease...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabio Massimo Perrotta, Fulvia Ceccarelli, Cristiana Barbati, Tania Colasanti, Antonia De Socio, Silvia Scriffignano, Cristiano Alessandri, Ennio Lubrano
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/9101964
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items